Presolicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF is planning to procure a BD Biosciences FACSymphony A3 Cell Analyzer for the Critical Care Medicine Department (CCMD). The analyzer is used for analyzing cells and is intended to replace the current FACS Fortessa cell analyzer manufactured by BD Biosciences. The BD FACS Symphony A3 cell analyzer must have various capabilities including up to 5 lasers, 30 parameters with 28 colors, state-of-the-art fiber optics, air-cooled lasers, and easily replaceable optical filters and mirrors. It should also have sensitivity and software features for performing real-time statistics and quality control. The analyzer must be capable of analyzing at least 30 logical gates and have low noise digital acquisition electronics. It should also be able to sample from a 96 well microtiter plates with the High Throughput Sampler. BD Biosciences is the sole manufacturer of the BD FACSymphony A3 Cell Analyzer and provides the necessary maintenance support and services. This acquisition is being conducted as a sole source procurement. Interested parties capable of providing similar products or services may submit a capability statement. The closing date for capability statements is July 30, 6:30AM EST.